Skip to content
Dx

ICD-10-CM 2027 diagnosis code

R87.2Abnormal level of other drugs, medicaments and biological substances in specimens from female genital organs

✓ Billable / specificFemale only

R87.2 is a valid, billable ICD-10-CM code for abnormal level of other drugs, medicaments and biological substances in specimens from female genital organs. It can be reported on claims for dates of service from October 1, 2026 – September 30, 2027.Short description: Abn lev drug/meds/biol subst in specmn from fem gntl organs

Code unchanged since ICD-10-CM took effect on October 1, 2015. Source: official FY2027 ICD-10-CM release from CDC/NCHS and CMS. Page updated September 29, 2026. About our data

About R87.2

R87.2 is the ICD-10-CM diagnosis code for abnormal level of other drugs, medicaments and biological substances in specimens from female genital organs. It belongs to category R87 (abnormal findings in specimens from female genital organs), block R83-R89 (abnormal findings on examination of other body fluids, substances and tissues, without diagnosis) and chapter 18 (symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified). It is billable, so it can be reported on its own for dates of service from October 1, 2026 through September 30, 2027.

Within R87, choose R87.2 (Abnormal level of other drugs, medicaments and biological substances in specimens from female genital organs) only when documentation doesn't support a more specific option: abnormal level of enzymes in specimens from female genital organs (R87.0), abnormal level of hormones in specimens from female genital organs (R87.1), abnormal level of substances chiefly nonmedicinal as to source in specimens from female genital organs (R87.3), abnormal immunological findings in specimens from female genital organs (R87.4), abnormal microbiological findings in specimens from female genital organs (R87.5), abnormal cytological findings in specimens from female genital organs (R87.6), abnormal histological findings in specimens from female genital organs (R87.7), other abnormal findings in specimens from female genital organs (R87.8) and 1 more.

It is not a CC or MCC, so as a secondary diagnosis it doesn't change the MS-DRG severity level.

In MS-DRG v44.0, it is part of the grouping logic for DRG 947 (Signs and Symptoms with MCC, relative weight 1.261) and DRG 948 (Signs and Symptoms without MCC, relative weight 0.7835), in MDC 23 (Factors Influencing Health Status and Other Contacts with Health Services), as a principal or secondary diagnosis. The DRG a claim lands in depends on the principal diagnosis, procedures and any CC/MCC secondary diagnoses.

It is on the CMS list of diagnoses consistent only with female patients (the sex-conflict edit itself was retired in FY2025).

It has been part of ICD-10-CM since the code set took effect on October 1, 2015 and hasn't changed since.

Before ICD-10, this condition was coded in ICD-9-CM as 792.9 (other nonspecific abnormal findings in body substances).

Notes that apply from higher levels

Instructions written at a parent level also apply to R87.2.

› From R87 Abnormal findings in specimens from female genital organs
Includes
  • abnormal findings in secretion and smears from cervix uteri
  • abnormal findings in secretion and smears from vagina
  • abnormal findings in secretion and smears from vulva

Broader instructions also apply from R83-R89 Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis and Chapter 18: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified.

Alphabetic index entries

1 entries

Terms in the official ICD-10-CM index that lead to R87.2.

MS-DRG v44.0 grouping

All DRGs →

Inpatient MS-DRGs this diagnosis can group to, as the principal or a secondary diagnosis, depending on the rest of the claim.

MDC 23 · Factors Influencing Health Status and Other Contacts with Health Services

ICD-9-CM equivalent

Converter →
  • 792.9Other nonspecific abnormal findings in body substancesapproximate

From the CMS 2018 General Equivalence Mappings (GEMs), the final GEMs release.

Code history

  1. 2016
  2. 2017
  3. 2018
  4. 2019
  5. 2020
  6. 2021
  7. 2022
  8. 2023
  9. 2024
  10. 2025
  11. 2026
  12. 2027
  • FY2016 (effective 10/1/2015): Added (first year of ICD-10-CM)
  • No changes since FY2016.

Common questions about R87.2

Is R87.2 billable?

Yes. R87.2 is a billable/specific ICD-10-CM code valid for FY2027 (October 1, 2026 – September 30, 2027).

Can R87.2 be used as a principal diagnosis?

Yes. The Medicare Code Editor doesn't restrict R87.2 as a principal diagnosis.

Is R87.2 a CC or MCC?

No. R87.2 is neither a CC nor an MCC under MS-DRG v44.0.

What DRG does R87.2 group to?

R87.2 is used in the MS-DRG v44.0 logic for MS-DRG 947 (Signs and Symptoms with MCC) and MS-DRG 948 (Signs and Symptoms without MCC). Which one applies depends on whether it is the principal diagnosis and on the rest of the claim.

What is the ICD-9 code for R87.2?

The CMS General Equivalence Mappings map R87.2 to ICD-9-CM 792.9.